1291114

Matthew G. Davis, M.D. — FEI 3007220553

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 10, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rochester, NY (United States)

Additional Details

Clinical Investigator (CI)